Literature DB >> 10823574

Ts65Dn mouse, a Down syndrome model, exhibits elevated myo-inositol in selected brain regions and peripheral tissues.

H U Shetty1, R J Siarey, Z Galdzicki, J Stoll, S I Rapoport.   

Abstract

myo-Inositol is elevated in the Down syndrome (DS; trisomy 21) brain and may play a role in mental retardation. In the present study, we examined brain regions and peripheral tissues of Ts65Dn mouse, a recently characterized genetic model of DS, for abnormal myo-inositol accumulation. A GC/MS technique was used to quantitate myo-inositol and other polyol species (ribitol, arabitol, xylitol, and 1,5-anhydrosorbitol) in tissues from the Ts65Dn mice and control diploid mice. myo-Inositol was found to be elevated in frontal cortex, hippocampus, and brain stem but not in cerebellum of the Ts65Dn mouse. Among peripheral organs examined, liver and skeletal muscle were found to excessively accumulate myo-inositol. In all tissues, concentrations of polyol internal controls were normal. The Ts65Dn mouse is useful to study the possible effect of elevated myo-inositol on cellular processes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10823574     DOI: 10.1023/a:1007592006005

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  28 in total

1.  Increased expression of voltage-activated calcium channels in cultured hippocampal neurons from mouse trisomy 16, a model for Down syndrome.

Authors:  Z Galdzicki; E J Coan; S I Rapoport; J Stoll
Journal:  Brain Res Mol Brain Res       Date:  1998-05

2.  Capillary gas chromatography combined with ion trap detection for quantitative profiling of polyols in cerebrospinal fluid and plasma.

Authors:  H U Shetty; H W Holloway; S I Rapoport
Journal:  Anal Biochem       Date:  1995-01-01       Impact factor: 3.365

3.  Purification of phosphatidylinositol synthetase from rat brain by CDP-diacylglycerol affinity chromatography and properties of the purified enzyme.

Authors:  A Ghalayini; J Eichberg
Journal:  J Neurochem       Date:  1985-01       Impact factor: 5.372

4.  Altered long-term potentiation in the young and old Ts65Dn mouse, a model for Down Syndrome.

Authors:  R J Siarey; J Stoll; S I Rapoport; Z Galdzicki
Journal:  Neuropharmacology       Date:  1997 Nov-Dec       Impact factor: 5.250

5.  Rapid and transient up-regulation of Na+/myo-inositol cotransporter transcription in the brain of acute hypernatremic rats.

Authors:  Y Minami; K Inoue; S Shimada; H Morimura; A Miyai; A Yamauchi; T Matsunaga; M Tohyama
Journal:  Brain Res Mol Brain Res       Date:  1996-08

6.  A mouse model for Down syndrome exhibits learning and behaviour deficits.

Authors:  R H Reeves; N G Irving; T H Moran; A Wohn; C Kitt; S S Sisodia; C Schmidt; R T Bronson; M T Davisson
Journal:  Nat Genet       Date:  1995-10       Impact factor: 38.330

7.  Concentration of myo-inositol in skeletal muscle of the rat occurs without active transport.

Authors:  B A Molitoris; I E Karl; W H Daughaday
Journal:  J Clin Invest       Date:  1980-04       Impact factor: 14.808

8.  Osmoregulatory alterations in myo-inositol uptake by bovine lens epithelial cells. Part 2: Cloning of a 626 bp cDNA portion of a Na+/myo-inositol cotransporter, an osmotic shock protein.

Authors:  C Zhou; N Agarwal; P R Cammarata
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-03       Impact factor: 4.799

9.  Cultured hippocampal neurons from trisomy 16 mouse, a model for Down's syndrome, have an abnormal action potential due to a reduced inward sodium current.

Authors:  Z Galdzicki; E Coan; S I Rapoport
Journal:  Brain Res       Date:  1993-02-26       Impact factor: 3.252

10.  Polyol profiles in Down syndrome. myo-Inositol, specifically, is elevated in the cerebrospinal fluid.

Authors:  H U Shetty; M B Schapiro; H W Holloway; S I Rapoport
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

View more
  4 in total

1.  Abnormal expression of the G-protein-activated inwardly rectifying potassium channel 2 (GIRK2) in hippocampus, frontal cortex, and substantia nigra of Ts65Dn mouse: a model of Down syndrome.

Authors:  Chie Harashima; David M Jacobowitz; Jassir Witta; Rosemary C Borke; Tyler K Best; Richard J Siarey; Zygmunt Galdzicki
Journal:  J Comp Neurol       Date:  2006-02-10       Impact factor: 3.215

2.  Knockdown of Myo-Inositol Transporter SMIT1 Normalizes Cholinergic and Glutamatergic Function in an Immortalized Cell Line Established from the Cerebral Cortex of a Trisomy 16 Fetal Mouse, an Animal Model of Human Trisomy 21 (Down Syndrome).

Authors:  Ana María Cárdenas; Paola Fernández-Olivares; Ignacio Díaz-Franulic; Arlek M González-Jamett; Takeshi Shimahara; Juan Segura-Aguilar; Raúl Caviedes; Pablo Caviedes
Journal:  Neurotox Res       Date:  2017-07-10       Impact factor: 3.911

3.  Quantitative analysis of myo-inositol in urine, blood and nutritional supplements by high-performance liquid chromatography tandem mass spectrometry.

Authors:  Kit-Yi Leung; Kevin Mills; Katie A Burren; Andrew J Copp; Nicholas D E Greene
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2011-08-06       Impact factor: 3.205

Review 4.  Molecular genetic analysis of Down syndrome.

Authors:  David Patterson
Journal:  Hum Genet       Date:  2009-06-13       Impact factor: 4.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.